Sagimet Biosciences (SGMT) Non-cash Items (2022 - 2026)
Sagimet Biosciences (SGMT) recorded quarterly Non-cash Items of $4.0 million in Q1 2026, up 5.23% quarter-over-quarter from $3.8 million in Q4 2025, and up 45.83% on a YoY basis from $2.7 million in Q1 2025.
Sagimet Biosciences (SGMT) Non-cash Items (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Non-cash Items history runs 5 years deep, the most recent figure standing at $4.0 million for Q1 2026.
- In Q1 2026, Non-cash Items rose 45.83% year-over-year to $4.0 million; the TTM figure through Mar 2026 stood at $4.0 million (up 45.83% YoY), while the FY2025 annual figure was $477467.0, down 81.06% from the prior year.
- Non-cash Items was $4.0 million for Q1 2026 at Sagimet Biosciences, up from $3.8 million in the prior quarter.
- In the past five years, Non-cash Items ranged from a high of $21.3 million in Q2 2023 to a low of $8000.0 in Q4 2023.
- Historically, Non-cash Items has averaged $5.1 million across 5 years, with a median of $3.4 million in 2025.
- The sharpest annual moves came in 2023 and 2024: Non-cash Items plunged 99.8% in 2023, then surged 7637.5% in 2024.
- A 5-year view of Non-cash Items shows it stood at $4.0 million in 2022, then slumped by 99.8% to $8000.0 in 2023, then soared by 7637.5% to $619000.0 in 2024, then jumped by 513.73% to $3.8 million in 2025, then advanced by 5.23% to $4.0 million in 2026.
- The last three Non-cash Items figures came in at $4.0 million (Q1 2026), $3.8 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - |
| 10 | Sagimet Biosciences | 211.96 Mn | 211.96 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.00 Mn |
| Mar 31, 2026 | 4.00 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Dec 31, 2025 | 3.80 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Jun 30, 2025 | 3.14 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Mar 31, 2025 | 2.74 Mn |
| Dec 31, 2024 | 619,000.00 |
| Dec 31, 2024 | 619,000.00 |
| Sep 30, 2024 | 9.50 Mn |
| Sep 30, 2024 | 9.50 Mn |
| Jun 30, 2024 | 10.30 Mn |
| Jun 30, 2024 | 10.30 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Mar 31, 2024 | 2.27 Mn |
| Dec 31, 2023 | 8,000.00 |
| Dec 31, 2023 | 8,000.00 |